Form 4 Tracker
LABCORP HOLDINGS INC.
LH

83 insider filings · Latest: Sep 1, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 11, 2025Jun 11 8:29 PMKERRII ANDERSON
Proposed Sale
1,000$259.37$259.4K—

View →

Jun 3, 2025Jun 3 3:55 PMCaveney Brian J
Proposed Sale
2,000$247.00$494.0K—

View →

May 13, 2025May 13 6:59 PMEISENBERG GLENN A
Proposed Sale
15,000$250.42$3.8M—

View →

May 12, 2025May 12 1:43 PMSchechter Adam H
Proposed Sale
6,105$248.73$1.5M—

View →

May 1, 2025May 1 3:07 PMvan der Vaart Sandra D
Proposed Sale
1,900$238.36$452.9K—

View →

Mar 28, 2025Mar 28 3:27 PMSchroeder Mark S
Proposed Sale
2,635$231.67$610.5K—

View →

Mar 28, 2025Mar 28 3:02 PMSummy Amy B.
Proposed Sale
758$231.67$175.6K—

View →

Mar 5, 2025Mar 5 9:08 PMKERRII B ANDERSON
Proposed Sale
500$255.63$127.8K—

View →

Feb 28, 2025Feb 28 3:15 PMSchroeder Mark S
Proposed Sale
5,339$249.23$1.3M—

View →

Feb 25, 2025Feb 25 3:15 PMvan der Vaart Sandra D
Proposed Sale
1,314$251.30$330.2K—

View →

Feb 24, 2025Feb 24 3:13 PMSummy Amy B.
Proposed Sale
226$250.40$56.6K—

View →

Feb 11, 2025Feb 11 2:40 PMSchechter Adam H
Proposed Sale
6,121$244.62$1.5M—

View →

Jan 7, 2025Jan 7 9:18 PMKERRII B ANDERSON
Proposed Sale
1,000$229.92$229.9K—

View →

Dec 2, 2024Dec 2 9:15 PMEISENBERG GLENN A
Proposed Sale
11,711$240.43$2.8M—

View →

Dec 2, 2024Dec 2 8:36 PMGilliland Dwight Gary
Proposed Sale
1,000$241.00$241.0K—

View →

Nov 22, 2024Nov 22 9:56 PMSummy Amy B.
Proposed Sale
3,672$238.87$877.1K—

View →

Nov 21, 2024Nov 21 8:20 PMvan der Vaart Sandra D
Proposed Sale
1,000$239.42$239.4K—

View →

Oct 24, 2024Oct 24 8:21 PMKERRII B ANDERSON
Proposed Sale
1,000$219.90$219.9K—

View →

Sep 3, 2024Sep 3 8:32 PMDiVincenzo Jonathan P.
Proposed Sale
5,461$229.62$1.3M—

View →

Sep 3, 2024Sep 3 6:23 PMDiVincenzo Jonathan P.
Proposed Sale
5,460$229.66$1.3M—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Feb 7, 2026Feb 10 8:06 PMDer Vaart Sandra D VanEVP, Corporate Affairs
Option Exercise
353—1,517(D)

View →

Feb 6, 2026Feb 10 8:06 PMDer Vaart Sandra D VanEVP, Corporate Affairs
Option Exercise
387—1,870(D)

View →

Feb 7, 2026Feb 10 8:05 PMBryan T VaughnEVP, Diagnostics
Option Exercise
178—3,624(D)

View →

Feb 6, 2026Feb 10 8:05 PMBryan T VaughnEVP, Diagnostics
Option Exercise
180—3,802(D)

View →

Feb 7, 2026Feb 10 8:04 PMJonathan C MeltzerEVP, Operations
Option Exercise
263—2,317(D)

View →

Feb 6, 2026Feb 10 8:04 PMJonathan C MeltzerEVP, Operations
Option Exercise
267—2,580(D)

View →

Feb 7, 2026Feb 10 8:02 PMKathryn W KyleEVP, Chief Legal Officer
Option Exercise
178—1,600(D)

View →

Feb 6, 2026Feb 10 8:02 PMKathryn W KyleEVP, Chief Legal Officer
Option Exercise
180—1,778(D)

View →

Feb 7, 2026Feb 10 8:01 PMAnita Z GrahamEVP, CHRO
Option Exercise
367—1,397(D)

View →

Feb 6, 2026Feb 10 8:01 PMAnita Z GrahamEVP, CHRO
Option Exercise
327—1,764(D)

View →

Feb 7, 2026Feb 10 8:00 PMAmy B. SummyEVP, Chief Marketing Officer
Option Exercise
222—914(D)

View →

Feb 6, 2026Feb 10 8:00 PMAmy B. SummyEVP, Chief Marketing Officer
Option Exercise
223—1,136(D)

View →

Feb 7, 2026Feb 10 7:58 PMMegan D. BaileyEVP, Pres, Central Labs & Intl
Option Exercise
289—2,130(D)

View →

Feb 6, 2026Feb 10 7:58 PMMegan D. BaileyEVP, Pres, Central Labs & Intl
Option Exercise
180—2,419(D)

View →

← Previous

Page 4 of 4